Clinical TrailsNovo Nordisk’s Evoke Phase 3 Trial Fails to Show Semaglutide Benefit in A... Novo Nordisk’s Evoke Phase 3 Trial Fails to Show Semaglutide Benefit in A... Read Post »
Clinical TrailsNew Hope for Stroke Survivors: Bayer’s Asundexian Shows Promise in Reduci... New Hope for Stroke Survivors: Bayer’s Asundexian Shows Promise in Reduci... Read Post »
Drugs Safety Alert ResearchThe Truth about “Ozempic Penis”: What Men Should Know About Semaglutide... The Truth about “Ozempic Penis”: What Men Should Know About Semaglutide... Read Post »
Health Tidings ResearchEli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Eli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Read Post »
New Drug ApprovalKoselugo Approved by FDA for Adults with Neurofibromatosis Type 1: A New Tr... Koselugo Approved by FDA for Adults with Neurofibromatosis Type 1: A New Tr... Read Post »
New Drug ApprovalFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ with Padcev® ... FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ with Padcev® ... Read Post »
Drugs Safety Alert ResearchFDA Investigates Fatal Case of Neutralizing Antibodies to ADAMTS13 after Ad... FDA Investigates Fatal Case of Neutralizing Antibodies to ADAMTS13 after Ad... Read Post »
New Drug ApprovalFDA Grants Full Approval to AbbVie’s EPKINLY® (epcoritamab-bysp) Plu... FDA Grants Full Approval to AbbVie’s EPKINLY® (epcoritamab-bysp) Plu... Read Post »
Clinical TrailsPfizer’s Next-Gen mRNA Flu Shot: A New Standard in Vaccine Innovation Pfizer’s Next-Gen mRNA Flu Shot: A New Standard in Vaccine Innovation Read Post »
Clinical TrailsAgios’ Mitapivat Delivers Positive Hemoglobin Gains but Mixed Pain‑Cr... Agios’ Mitapivat Delivers Positive Hemoglobin Gains but Mixed Pain‑Cr... Read Post »
Clinical TrailsMerck Announces Positive Topline Results from Pivotal Phase 3 Trial of Dora... Merck Announces Positive Topline Results from Pivotal Phase 3 Trial of Dora... Read Post »
New Drug ApprovalFDA Clears Regeneron and Bayer’s EYLEA HD® for Macular Edema after R... FDA Clears Regeneron and Bayer’s EYLEA HD® for Macular Edema after R... Read Post »
Clinical TrailsNovo Nordisk’s Wegovy® (Semaglutide 2.4 mg) Delivers Liver Health Benefi... Novo Nordisk’s Wegovy® (Semaglutide 2.4 mg) Delivers Liver Health Benefi... Read Post »
Clinical TrailsLibrexia ACS Trial Ends Early as Efficacy Endpoint Not Met, BMS and J&J... Librexia ACS Trial Ends Early as Efficacy Endpoint Not Met, BMS and J&J... Read Post »
New Drug ApprovalFDA Approves Redemplo (Plozasiran) to Lower Triglycerides in Adults with Fa... FDA Approves Redemplo (Plozasiran) to Lower Triglycerides in Adults with Fa... Read Post »
Clinical TrailsWINREVAIR Shows Promising Phase 2 Results in CpcPH with HFpEF WINREVAIR Shows Promising Phase 2 Results in CpcPH with HFpEF Read Post »
New Drug ApprovalEMA CHMP November 2025: Ten New Medicines Recommended for Approval EMA CHMP November 2025: Ten New Medicines Recommended for Approval Read Post »
New Drug ApprovalSandoz Launches Tyruko® in US, First Biosimilar to Biogen’s Tysabri, Enh... Sandoz Launches Tyruko® in US, First Biosimilar to Biogen’s Tysabri, Enh... Read Post »
Clinical TrailsJohnson & Johnson’s TREMFYA® Confirms Unique Joint Protection in Pso... Johnson & Johnson’s TREMFYA® Confirms Unique Joint Protection in Pso... Read Post »
Clinical TrailsHow AUSTEDO and AUSTEDO XR Improve Quality of Life in Tardive Dyskinesia Pa... How AUSTEDO and AUSTEDO XR Improve Quality of Life in Tardive Dyskinesia Pa... Read Post »
Clinical TrailsVir Biotechnology’s Tobevibart & Elebsiran Combo Achieves Breakth... Vir Biotechnology’s Tobevibart & Elebsiran Combo Achieves Breakth... Read Post »
Drugs Safety Alert ResearchSarepta’s ELEVIDYS Updated FDA Labeling: New Boxed Warning and Narrow... Sarepta’s ELEVIDYS Updated FDA Labeling: New Boxed Warning and Narrow... Read Post »
Lifestyle ResearchHow Quitting Tobacco Adds Years to HIV and Tuberculosis Patients’ Lives How Quitting Tobacco Adds Years to HIV and Tuberculosis Patients’ Lives Read Post »
Clinical TrailsVertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Vertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Read Post »
Clinical TrailsGilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Read Post »
Clinical TrailsRegeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Regeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Read Post »
Clinical TrailsAmgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Amgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Read Post »
Clinical TrailsLivdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Livdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Read Post »
Clinical TrailsGanaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Ganaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Read Post »
Clinical TrailsAstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... AstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... Read Post »
Clinical TrailsHope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Hope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Read Post »
Clinical TrailsBayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Bayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Read Post »
Clinical TrailsFirst Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... First Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... Read Post »
Clinical TrailsRoche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Roche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Read Post »
Disease & Drugs Drugs Safety Alert ResearchFDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... FDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... Read Post »
Health Tidings ResearchNovo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Novo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Read Post »
Clinical TrailsAtacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Atacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Read Post »
New Drug ApprovalFDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... FDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... Read Post »
Clinical TrailsEli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Eli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Read Post »
Drugs Safety Alert ResearchFDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... FDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... Read Post »
Clinical TrailsRoche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Roche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Read Post »
New Drug ApprovalInnovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Innovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Read Post »
New Drug ApprovalKygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Kygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Read Post »
Clinical TrailsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... Read Post »
ResearchSemaglutide Users Report Major Reduction in “Food Noise” and Better Men... Semaglutide Users Report Major Reduction in “Food Noise” and Better Men... Read Post »
Clinical TrailsGefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Gefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Read Post »
Drugs Safety Alert ResearchFDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... FDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... Read Post »
Drugs Safety Alert ResearchTeva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Teva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Read Post »
Clinical TrailsNovartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Novartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Read Post »
Clinical TrailsBridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... BridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... Read Post »
